Oakland, CA, United States of America

Elisa Franco


Average Co-Inventor Count = 4.9

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elisa Franco: Innovator in Protein and Nucleic Acid Regulation

Introduction

Elisa Franco is a prominent inventor based in Oakland, CA. She has made significant contributions to the field of molecular biology, particularly in the regulation of proteins and nucleic acids. With a total of 3 patents, her work has the potential to impact various applications in biotechnology and medicine.

Latest Patents

Franco's latest patents include innovative compositions and methods for regulating protein and nucleic acid activities. One of her notable patents focuses on compositions and methods for conditionally regulating activities of CRISPR-Cas systems. This method involves providing an inactive guide RNA with a regulatory domain that can be activated by a trigger nucleic acid, allowing for precise control over gene editing processes. Another significant patent addresses inhibitors of RNA-guided nucleases, providing methods for inhibiting the function of RNA-guided endonucleases and identifying such inhibitors for practical applications.

Career Highlights

Throughout her career, Elisa Franco has worked with esteemed institutions, including The Brigham and Women's Hospital and the University of California. Her research has contributed to advancements in genetic engineering and therapeutic development, showcasing her expertise in the field.

Collaborations

Franco has collaborated with notable colleagues such as Amit Choudhary and Kurt Cox, further enhancing her research and innovation efforts. These collaborations have allowed her to expand her work and explore new avenues in molecular biology.

Conclusion

Elisa Franco's contributions to the field of protein and nucleic acid regulation highlight her role as an influential inventor. Her innovative patents and collaborations reflect her commitment to advancing biotechnology and improving therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…